Connection

Peter Verhamme to Atrial Fibrillation

Back to Details
This is a "connection" page, showing publications Peter Verhamme has written about Atrial Fibrillation.
Peter Verhamme
Connection Strength
0.413
Atrial Fibrillation
  1. Idarucizumab for the reversal of dabigatran in patients undergoing heart transplantation. Eur J Heart Fail. 2019 01; 21(1):129-131.
    View in: PubMed
    Score: 0.268
  2. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. Europace. 2018 08 01; 20(8):1231-1242.
    View in: PubMed
    Score: 0.065
  3. The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018 04 21; 39(16):1330-1393.
    View in: PubMed
    Score: 0.064
  4. Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry. Intern Emerg Med. 2018 Oct; 13(7):1051-1058.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.